It’s official: Aurora Cannabis will get competing MedReleaf for C$2.9B
Aurora Cannabis Inc. is placing a final end to all the speculations by announcing so it has consented to purchase competing cannabis company MedReleaf Corp. for nearly C$3 billion.
Final month, there has been speaks concerning the two businesses negotiating a mega merger. Even though Aurora Cannabis and MedReleaf later confirmed which they were certainly in conversations regarding alternatives that are“various” they clarified that they hadn’t entered into any sort of deal to impact this kind of deal. In addition they noticed that their conversations may well not cause any contract.
The merger strengthens their ability to program the quickly growing globalmedical marijuana markets, also amplifies the company’s early-mover advantage. – Aurora Chief Executive Officer Terry Booth